Research Article

Donor Blood Procurement, Safety, and Clinical Utilization: A Study of Blood Transfusion Services in a Tertiary Care Hospital in Nigeria

Table 4

Seroprevalence of blood-borne diseases among persons screened during the study period.

TTIDonor groupPositive (%)Negative (%)Total N (%)Chi square valueRelative risk

VNRD1 (0.37)268 (99.63)269 (100.0)1
HIVFRD87 (0.95)9037 (99.05)9124 (100.0)4.9520.0842.56
PAID13 (0.49)2625 (99.51)2638 (100.0)1.33
Total101 (0.82)11930 (99.18)12031 (100.0)
VNRD4 (1.50)263 (98.50)267 (100.0)1
HBVFRD230 (2.52)8894 (97.48)9124 (100.0)14.9400.0011.68
PAID33 (1.25)2602 (98.75)2635 (100.0)0.84
Total267 (2.22)11759 (97.78)12026 (100.0)
VNRD8 (3.0)259 (97.0)267 (100.0)1
HCVFRD199 (2.18)8925 (97.82)9124 (100.0)9.93920.0090.73
PAID33 (1.26)2595 (98.74)2628 (100.0)0.42
Total240 (2.00)11779 (98.0)12019 (100.0)
VNRD5 (1.87)262 (98.13)267 (100.0)1
SyphilisFRD203 (2.22)8921 (97.78)9124 (100.0)19.4730.000061.19
PAID22 (0.84)2598 (99.16)2620 (100.0)0.45
Total230 (1.91)11781 (98.09)12011